Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors.

Fernando Sebastian-VallesBlanca Bernaldo MadridCarolina SagerElena Carrillo LópezSara Mera CarreiroLaura Ávila AntónNoelia Sánchez-Maroto GarcíaMiguel Antonio Sampedro-NuñezJose Ángel Díaz PérezMónica Marazuela

Published in: Biomedicines (2023)

Chronic treatment with SSA is a feasible option for recurrent GC-1s that are difficult to manage using endoscopy or gastrectomy. Randomized clinical trials to provide more scientific evidence are still needed.

Keyphrases

neuroendocrine tumors
high resolution
molecular docking
replacement therapy
tandem mass spectrometry
simultaneous determination
small bowel